JOURNAL BROWSE
Search
Advanced SearchSearch Tips
The effects of Cudrania tricuspidata extract on bone metabolism in ovariectomized rats
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
The effects of Cudrania tricuspidata extract on bone metabolism in ovariectomized rats
Jo, You-Young; Seo, Sang Deog; Kim, Ji-Won; Cho, Hyun-Ji; Chon, Jeong-Woo; Lee, Kwang Gill; Lee, Heui-Sam; Park, Yoo-Kyoung; Kweon, HaeYong;
  PDF(new window)
 Abstract
The effects of Cudrania tricuspidata (CT) extract on markers of osteoporosis were examined in ovariectomized rats. We classified 26 rats into five groups and provided a pellet chow diet and tap water throughout the 27-wk experimental period. During the last 15 wk, we added oral injections to each group as follows: sham-operated (SHAM, n
 Keywords
Cudrania tricuspidata;medicinal herbs;osteocalcin;bone metabolism;ovariectomized rat;
 Language
English
 Cited by
 References
1.
Arslan A, Orkun S, Aydin G, Keles I, Tosun A, Arslan M, Caglayan O (2011) Effects of ovariectomy and ascorbic acid supplement on oxidative stress parameters and bone mineral density in rats. Libyan J Med 6, 5965. crossref(new window)

2.
Ataoğlu MB, Atik OS, Gül O, Sarıkaya B, Görmeli G, Oztürk BY, Ozgürol B (2013) A comparison of the measurements with biochemical markers of bone turnover and bone mineral density in the assessment of the efficiency of osteoporosis treatment. Eklem Hast Cerrahisi 24, 82-86. crossref(new window)

3.
Baeksgaard L, Andersen KP, Hyldstrup L (1998) Calcium and vitamin D supplementation increases spinal BMD in healthy, postmenopausal women. Osteoporosis Int 8, 255-260. crossref(new window)

4.
Bharadwaj S, Naidu AGT, Betageri GV, Prasadarao NV, Naidu AS (2009) Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women. Osteoporosis Int 20, 1603-1611. crossref(new window)

5.
Chen WF, Mok SK, Wang XL, Lai KH, Lai WP, Luk HK, Leung PC, Yao XS, Wong MS (2011) Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice. Brit JNutr 105, 180-189. crossref(new window)

6.
Choi MJ Kim MS (2011) Effect of Dietary Vitamin K2 Supplementation on Bone Mineral Density in Ovariectomized Rats. Korean J Nutr 44, 189-195. crossref(new window)

7.
Choi YJ, Oh HJ, Kim DJ, Lee Y, Chung Y (2012) The prevalence of osteoporosis in Korean adults aged 50 years or older and the higher diagnosis rates in women who were beneficiaries of a national screening program: The Korea National Health and Nutrition Examination Survey 2008–2009. J Bone Miner Res 27, 1879-1886. crossref(new window)

8.
Dandinoğlu T, Akarsu S, Karadeniz M, Tekin L, Arıbal S, Kıralp MZ (2013) Can long-term bisphosphonate use causes low-energy fractures? A case report. Osteoporosis Int 25, 773-776. crossref(new window)

9.
Epstein S, Delmas PD, Emkey R, Wilson KM, Hiltbrunner V, Schimmer RC (2006) Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety. Maturitas 54, 1-10. crossref(new window)

10.
Goffinet M, Thoulouzan M, Pradines A, Lajoie-Mazenc I, Weinbaum C, Faye jC, Seronie-Vivien S (2006) Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells. BMC Cancer 6, 60. crossref(new window)

11.
Green J, Czanner G, Reeves G, Watson J, Wise L, Beral V (2010) Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ- Brit Med J 341, c4444. crossref(new window)

12.
Halasy-Nagy JM, Rodan GA, Reszka AA (2001) Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone 29, 553-559. crossref(new window)

13.
Imai K (2013) Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation. Clin Interv Aging 8, 681-688. crossref(new window)

14.
Kalu DN (1991) The ovariectomized rat model of postmenopausal bone loss. Bone and mineral 15, 175-191. crossref(new window)

15.
Kanis JA, McCloskey EV (1996) Evaluation of the risk of hip fracture. Bone 18, S127-S132. crossref(new window)

16.
Karsenty G, Oury F (2013) Regulation of male fertility by the bone-derived hormone osteocalcin. Mol Cell Endocrinol 382, 521-526. crossref(new window)

17.
Kennedy RL, Vangaveti V, Malabu UH, McCulloch D (2013) The vitamin K-dependent Gla proteins and risk of type 2 diabetes. Diabetologia 56, 2100-2101. crossref(new window)

18.
Kim MS Kim IA, Ko YJ, Jeong JA, Kim JE, Song BJ, Lim WB, Lim HS, Park JI, Kim SY, Choi HR,Kim OJ (2009) Methanol Extract of Leaves from Cudrania tricuspidata Effects in HT-29 Colorectal Adenocarcinoma. Kor J Oral Maxillofac Pathol 33, 19-26.

19.
Kweon H, Shin SH, Chon JW, Lee K, Jo Y, Yoon JY, Park Y, Jeon J, Kim J, Shin B (2015) Effects of silk fibroin hydrolysate on bone metabolism in ovariecomized rats. Int J Indust Entomol 30, 17-25. crossref(new window)

20.
Lauritzen JB (1996) Hip fractures: incidence, risk factors, energy absorption, and prevention. Bone 18, S65-S75. crossref(new window)

21.
Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee P J, McKee MD, Jung DY (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456-469. crossref(new window)

22.
Li N, Jiang Y, Wooley PH, Xu Z, Yang S (2013) Naringin promotes osteoblast differentiation and effectively reverses ovariectomy-associated osteoporosis. J Orthop Sci 18, 478-485. crossref(new window)

23.
Lim YW, Sun DH, Kim YS (2009) Etiology of Osteoporosis and Prevention of Osteoporotic Fractures (in Korean). J Kor Orthopedic Assoc 21, 6-16.

24.
Melton LJ, Cummings SR (1987) Heterogeneity of age-related fractures: implications for epidemiology. Bone and mineral 2, 321.

25.
Mizuguchi M, Fujisawa R, Nara M, Nitta K, Kawano K (2001) Fourier-transform infrared spectroscopic study of Ca2+-binding to osteocalcin. Calcified Tissue Int 69, 337-342. crossref(new window)

26.
Mundy GR (1991) Inflammatory mediators and the destruction of bone. J Periodontal Res 26, 213-217. crossref(new window)

27.
Nordin BEC (1997) Calcium and osteoporosis. Nutrition 13, 664-686. crossref(new window)

28.
Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CYC (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocr Metab 90, 1294-1301. crossref(new window)

29.
Puchacz E, Lian JB, Stein GS, Wozney J, Huebner K, Croce C (1989) Chromosomal localization of the human osteocalcin gene. Endocrinol 124, 2648-2650. crossref(new window)

30.
Rodan GA (1998) Mechanisms of action of bisphosphonates. Annu Rev Pharmacol Toxicol 38, 375-388 crossref(new window)

31.
Tranquilli AL, Lucino E, Garzetti GG, Romanini C (1994) Calcium, phosphorus and magnesium intakes correlate with bone mineral content in postmenopausal women. Gynecol Endocrinol 8, 55-58. crossref(new window)

32.
Vlasiadis KZ, Damilakis J, Velegrakis GA, Skouteris CA, Fragouli I, Goumenou A, Matalliotakis J, Koumantakis EE (2008) Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis. Maturitas 59, 226-233. crossref(new window)